CO21 Validation of Crossover Adjustment Outcomes in a Randomized Clinical Trial (RCT) Using Real-World Evidence (RWE) in Non-Small Cell Lung Cancer (NSCLC)
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.101
https://www.valueinhealthjournal.com/article/S1098-3015(22)02305-1/fulltext
Title :
CO21 Validation of Crossover Adjustment Outcomes in a Randomized Clinical Trial (RCT) Using Real-World Evidence (RWE) in Non-Small Cell Lung Cancer (NSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02305-1&doi=10.1016/j.jval.2022.09.101
First page :
Section Title :
Open access? :
No
Section Order :
10565